Clostridioides difficile (formerly Clostridium difficile) infection is a substantial health and
economic burden worldwide. Great strides have been made over the past several years in …

Clostridium butyricum is a human commensal bacterium with beneficial effects including
butyrate production, spore formation, increasing levels of beneficial bacteria, and inhibition …

The Gram-positive anaerobic bacterium Clostridioides difficile (CD) can produce intense
exotoxins, contributing to nosocomial infections, and it is the most common cause of health …

Background Clostridioides difficile is a spore forming bacterial species and the major
causative agent of nosocomial gastrointestinal infections. C. difficile spores are highly …

Objectives Clostridioides difficile infection (CDI) is a common healthcare-associated
infection and leading cause of gastroenteritis-related mortality worldwide. However, data on …

The recent discovery of the same Clostridioides difficile ribotypes associated with human
infection in a broad range of environments, animals and foods, coupled with an ever …

Background Current practice guidelines favour fidaxomicin over vancomycin and exclude
metronidazole from the recommended standard regimen for Clostridioides difficile infection …

Clostridioides difficile is a Gram-positive bacteria that causes nosocomial infections,
significantly impacting public health. In the present study, we aimed to describe the clinical …

Clostridium difficile (C. difficile) is an exclusively anaerobic, spore-forming, and Gram-
positive pathogen that is the most common cause of nosocomial diarrhea and is becoming …

Background This real-world study assessed the epidemiology and clinical complications of
Clostridioides difficile infections (CDIs) and recurrences (rCDIs) in hospital and community …